Navigation Links
Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
Date:11/19/2007

BEIJING, Nov. 19 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced an update on the clinical trials for its pandemic influenza vaccines. Sinovac received approval in April 2007 from the China State Food and Drug Administration (SFDA) to commence Phase Ib and II trials of its pandemic influenza (H5N1) whole viron inactivated vaccine and Phase I and II trials of its pandemic influenza (H5N1) split vaccine.

In the pandemic influenza whole viron vaccine Phase II trial, a total of 402 enrolled volunteers from 18 to 60 years old were vaccinated with doses of 5ug, 10ug or 15ug. In accordance with the Phase II trial protocol, all of the volunteers were vaccinated with two doses and followed for an observation period. There were no serious adverse events.

In the Phase I and Phase II trials for the split pandemic influenza vaccine, 160 volunteers from 3 to 70 years old, sorted into four different age groups, were enrolled. The volunteers received doses of 5ug, 10ug, 15ug or 30ug and were followed for an observation period. There were no serious adverse events.

Separately, Sinovac's external auditors are currently reviewing the Company's third quarter financial results, which the Company plans to disclose thereafter. Pertaining to the Annual General Meeting of Shareholders originally scheduled for August 2007, the Company did not receive at that time sufficient shareholder votes, given the geographical nature of its shareholders, to achieve a quorum, as per its corporate by-laws. Sinovac is diligently working to reschedule its Annual General Meeting.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(TM) (hepatitis A), Bilive(TM) (combined hepatitis A and B) and An
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
5. Raptor Pharmaceuticals Provides Update of Product Programs
6. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
7. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
11. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- A new survey of health care stakeholders ... will yield improvements in health care decision-making, but ... CER in the current environment. The National Pharmaceutical ... that they view CER as important, expect it ... decision-making in the next three to five years, ...
(Date:3/26/2015)... , March 26, 2015  Desert Valley Medical Center, ... times , is the first U.S. hospital to ... emergency department to help clinicians prevent hospital acquired pressure ... Victorville, Calif. , is a community hospital serving ... Using the Leaf Patient Monitor in the hospital,s emergency ...
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... to serve as a feature-rich resource for patients of its ... For those experiencing knee pain, the Gel-One Patient ... knee pain and helps them understand more about the potential ... non-surgical treatment option. For those who have had a ...
Breaking Medicine Technology:NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families ... during the game! It’s portable, lightweight and provides a wide ... a new line of specialty trail mixes that satisfy your ... packed with nutritious, 100% all natural ingredients. , These tasty ... protein and fiber to your diet and boost energy. The ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of the end ... bloodiest war and the amazing President that led our country ... the Civil War and Abraham Lincoln. This moving event will ... Jane Pickens Theater in Newport, RI. , Chief Justice ... the master of ceremonies. Dr. Fred Zilian, educator, writer and ...
(Date:3/27/2015)... San Diego, CA (PRWEB) March 27, 2015 ... in February 2015 (case number 1:15-cv-10429, U.S. District Court, ... District Court of the Eastern District of Pennsylvania), the ... of Melinda J. Helbock, A.P.C. are announcing that they ... on behalf of women who were prescribed Zofran ...
(Date:3/26/2015)... Let’s not lose focus of why ... today’s traffic magnets. Three out of 4 consumers choose ... produce department, according to a Packaged Facts survey. Produce ... looking to add more fruits and vegetables to their ... is April 2. As featured in the Chase’s Calendar ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2
... In keeping with its mission to provide ... administrators and board members, Educators Health Alliance (EHA) ... Advocate. This individual will provide cost-effective methods for ... district employees who participate in the plan. The ...
... Penn Author Urges Changes that Hold Health Care ... Even when their products are implicated in ... (HIT) currently enjoy wide contractual and legal protection ... Ph.D., of the University of Pennsylvania ...
... PRGO ; TASE) today announced that it ... Drug Administration to market Sulfacetamide Sodium Topical Suspension, 10% ... equivalent (AB) to Sanofi-Aventis, Klaron(R) (Sodium Sulfacetamide) Lotion, 10%, ... Klaron(R) Lotion had sales of approximately $15 million for ...
... Medicare Advocacy Recovery Coalition (MARC), a broad-based group ... its appreciation for the federal extension of the ... and other non-group health claims. By program memorandum, ... announced that it was extending implementation of the ...
... covered by the shot, study finds , , TUESDAY, March 24 ... New Mexico in the 1980s and 1990s contained DNA from ... says a new study. , It also found that women ... five years younger than those diagnosed with cancers associated with ...
... training, patient education and feedback, , , TUESDAY, March 24 ... better approach to helping people battle chronic pain, new ... than 400 U.S. veterans, researchers found that a collaborative ... education for patients in pain and their primary care ...
Cached Medicine News:Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 2Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 3Health News:Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) 2Health News:MARC Coalition Welcomes CMS Extension of MSP Reporting Requirements and Clarification of Reporting Thresholds 2Health News:HPV Data May Aid Vaccine's Effectiveness 2Health News:Collaborative Care Helps Ease Chronic Pain 2Health News:Collaborative Care Helps Ease Chronic Pain 3
... I Small Joint Arthroscopy ... a complete line of ... specifically designed for small ... available in a variety ...
The BioPro Basal Thumb joint is manufactured from Cobalt Chrome and is used to replace the Trapeziometacarpal joint....
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis....
... Implant System utilizes the same proven materials ... The SR™ Hand Implant System provides ... including minimal bone resection, surface replacement of ... retention and/or repositioning of the ligamentous soft ...
Medicine Products: